Growth hormone (somatropin) is the standard licensed treatment for short stature due to growth hormone deficiency and short stature in Turner's syndrome. It has recently been licensed for use by children with short stature due to chronic renal failure. The authors aim to examine how effective this treatment is, and whether it actually has any positive effects, medical or psychological.